Mineralocorticoid receptor blockade improves pulmonary hypertension and right ventricular function in bronchopulmonary dysplasia: a case report

Bronchopulmonary dysplasia (BPD) is a combined pulmonary vascular and parenchymal disease, representing the most common cause of chronic lung disease (CLD) in infancy. Pulmonary hypertension (PH) is frequently associated with BPD and—if persistent—substantially increases mortality. We report on a 4-...

Full description

Saved in:
Bibliographic Details
Published inCardiovascular diagnosis and therapy Vol. 10; no. 5; pp. 1686 - 1690
Main Authors Giagnorio, Roberto, Hansmann, Georg
Format Journal Article
LanguageEnglish
Published AME Publishing Company 01.10.2020
Subjects
Case Report on Right Ventricular Dysfunction
Online AccessGet full text

Cover

More Information
Summary:Bronchopulmonary dysplasia (BPD) is a combined pulmonary vascular and parenchymal disease, representing the most common cause of chronic lung disease (CLD) in infancy. Pulmonary hypertension (PH) is frequently associated with BPD and—if persistent—substantially increases mortality. We report on a 4-month-old, former preterm infant with BPD, severe PH and right heart failure who greatly and rapidly improved clinical status and right ventricular (RV) function by means of blood biomarkers [N-terminal prohormone of brain natriuretic peptide (NT-pro-BNP), cardiac troponin T] and transthoracic echocardiography, following the addition of spironolactone and hydrochlorothiazide to the treatment regimen.
ISSN:2223-3652
2223-3660
DOI:10.21037/cdt.2020.02.05